News Releases

DOT announces Amendments to Drug Testing Program

  • Dec 12, 2017

The Department of Transportation (DOT) announced that it is amending its drug testing program regulations as of January 1, 2018.

The following Opioids: hydrocodone, hydromorphone, oxymorphone, and oxycodone are being added to the DOT drug testing panel which already includes cocaine, marijuana, phencyclidine, amphetamine/methamphetamine and the opiates morphine and codeine. Some common names for these new opioids include OxyContin, Opana, Percodan, Percocet, Vicodin, Lortab, Norco, and Dilaudid.

The regulation change also removes the requirement for employers or TPA’s to submit blind specimens on an annual basis.

You can continue to use the existing Chain of Custody (COC) forms until further notice.

Sanford OccMed is prepared for the upcoming changes. In addition, our non-DOT look-alike send in full drug panels will be adjusted to match the new DOT urine drug panel. At the moment there is no DOT look-alike quick cup. Please review your company drug testing policy to ensure it is updated with these additional drugs.

For more information, contact Sanford OccMed drug testing division at 1-888-600-2378.